SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-23-012531
Filing Date
2023-08-23
Accepted
2023-08-23 13:08:32
Documents
2
Period of Report
2023-08-21

Document Format Files

Seq Description Document Type Size
1 form3-08232023_050825.html 3  
1 form3-08232023_050825.xml 3 1699
2 ex24-08232023_050826.htm EX-24 5797
  Complete submission text file 0001415889-23-012531.txt   9077
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Anderson Cynthia Lynn (Reporting) CIK: 0001989905 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 231196509